BioCentury | Jul 16, 2020
Emerging Company Profile

Fountain Therapeutics: an AI-based platform to reverse cellular aging

...cognitive decline based on its ability to improve memory in aged mice. Harvard University spinout Elevian Inc....
...Ventures CEO: John Dimos Patents: None issued Danielle Golovin, Staff Writer Fountain Therapeutics Nan Fung Life Sciences Khosla Ventures Alkahest Inc. Elevian Inc. Unity...
BioCentury | Oct 9, 2019
Company News

CTFH latest to partner with Insilico in AI discovery deal

...Insilico has partnered with at least two other companies this year, including a deal with Elevian Inc....
BioCentury | Feb 8, 2019
Finance

Extending a Bold vision for Longevity

...Bold invested in artificial intelligence company Insilico Medicine Inc. (Rockville, Md.) and regenerative medicine start-up Elevian Inc....
BioCentury | Jan 9, 2019
Company News

Elevian, AI company Insilico partner to find anti-aging candidates in GDF11 pathway

...Biotech" ). GDF11 - Growth differentiation factor 11; TGFβ - Transforming growth factor β Elizabeth S. Eaton Elevian Inc. Insilico...
BioCentury | Sep 28, 2018
Emerging Company Profile

GDF11 against aging

...Harvard University spinout Elevian Inc. is developing a regenerative platform around GDF11 to treat age-related diseases, including...
...targeting senescent cells, and Juvenescence Ltd., which is developing undisclosed therapeutics using AI. COMPANY PROFILE Elevian Inc....
...Fund, Kizoo Ventures, Thynk Capital CEO: Mark Allen Patents: None issued Companies and Institutions Mentioned Elevian Inc....
BioCentury | Sep 7, 2018
Financial News

Anti-aging Elevian debuts with $5.5M seed funding

...Regenerative medicine company Elevian Inc. (Allston, Mass.) launched on Sept. 6 with $5.5 million in seed funding...
...additional studies soon. Elevian Inc., Allston, Mass. Elizabeth S. Eaton Novartis Institute for Biomedical Research Growth differentiation factor 11 (GDF11) Elevian Inc....
Items per page:
1 - 6 of 6
BioCentury | Jul 16, 2020
Emerging Company Profile

Fountain Therapeutics: an AI-based platform to reverse cellular aging

...cognitive decline based on its ability to improve memory in aged mice. Harvard University spinout Elevian Inc....
...Ventures CEO: John Dimos Patents: None issued Danielle Golovin, Staff Writer Fountain Therapeutics Nan Fung Life Sciences Khosla Ventures Alkahest Inc. Elevian Inc. Unity...
BioCentury | Oct 9, 2019
Company News

CTFH latest to partner with Insilico in AI discovery deal

...Insilico has partnered with at least two other companies this year, including a deal with Elevian Inc....
BioCentury | Feb 8, 2019
Finance

Extending a Bold vision for Longevity

...Bold invested in artificial intelligence company Insilico Medicine Inc. (Rockville, Md.) and regenerative medicine start-up Elevian Inc....
BioCentury | Jan 9, 2019
Company News

Elevian, AI company Insilico partner to find anti-aging candidates in GDF11 pathway

...Biotech" ). GDF11 - Growth differentiation factor 11; TGFβ - Transforming growth factor β Elizabeth S. Eaton Elevian Inc. Insilico...
BioCentury | Sep 28, 2018
Emerging Company Profile

GDF11 against aging

...Harvard University spinout Elevian Inc. is developing a regenerative platform around GDF11 to treat age-related diseases, including...
...targeting senescent cells, and Juvenescence Ltd., which is developing undisclosed therapeutics using AI. COMPANY PROFILE Elevian Inc....
...Fund, Kizoo Ventures, Thynk Capital CEO: Mark Allen Patents: None issued Companies and Institutions Mentioned Elevian Inc....
BioCentury | Sep 7, 2018
Financial News

Anti-aging Elevian debuts with $5.5M seed funding

...Regenerative medicine company Elevian Inc. (Allston, Mass.) launched on Sept. 6 with $5.5 million in seed funding...
...additional studies soon. Elevian Inc., Allston, Mass. Elizabeth S. Eaton Novartis Institute for Biomedical Research Growth differentiation factor 11 (GDF11) Elevian Inc....
Items per page:
1 - 6 of 6